Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    19297572 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Recombinant CMV gB Vaccine in Postpartum Women
Condition: Cytomegalovirus Infections
Interventions: Biological: CMV gB vaccine;   Drug: MF59 adjuvant;   Drug: Placebo
2 Recruiting Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults
Condition: Cytomegalovirus Infections
Interventions: Drug: VBI-1501A;   Drug: VBI-1501;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.